Keywords

gestational diabetes mellitus, health management, metabolic syndrome, nurse-led, web-based

 

Authors

  1. SU, Mei-Chen

ABSTRACT

Background: Women with gestational diabetes mellitus (GDM) are more likely to develop metabolic syndrome (MS). However, the effectiveness of web-based health management in preventing women at high risk of GDM from developing MS has rarely been studied.

 

Purpose: The aim of this study was to evaluate the longitudinal effects of nurse-led web-based health management on maternal anthropometric, metabolic measures, and neonatal outcomes.

 

Methods: A randomized controlled trial was conducted from February 2017 to February 2018, in accordance with the Consolidated Standards of Reporting Trials guidelines. Data were collected from 112 pregnant women at high risk of GDM who had been screened from 984 potential participants in northern Taiwan. Participants were randomly assigned to the intervention group (n = 56) or the control group (n = 56). The intervention group received a 6-month nurse-led, web-based health management program as well as consultations conducted via the LINE mobile app. Anthropometric and metabolic measures were assessed at baseline (Time 0, prior to 28 weeks of gestation), Time 1 (36-40 weeks of gestation), and Time 2 (6-12 weeks of postpartum). Maternal and neonatal outcomes were assessed at delivery. Clinical trial was registered.

 

Results: Analysis using the general estimating equation models found that anthropometric and metabolic measures were significantly better in the intervention group than the control group and varied with time. At Time 1, the levels of diastolic pressure ([beta] = -4.981, p = .025) and triglyceride (TG; [beta] = -33.69, p = .020) were significantly lower in the intervention group than the control group, and at Time 2, the incidence of MS in the intervention group was lower than that in the control group ([chi]2 = 6.022, p = .014). The number of newborns with low birth weight in the intervention group was lower than that in the control group ([chi]2 = 6.729, p = .012).

 

Conclusion/Implications for Practice: This nurse-led, web-based health management was shown to be effective in improving MS outcomes and may play an important role and show feasible clinical value in changing the current pregnancy care model.

 

Article Content

Introduction

Gestational diabetes mellitus (GDM) refers to varying degrees of glucose intolerance that occur during pregnancy or are first diagnosed during pregnancy (Puhkala et al., 2017). GDM is a growing concern and is accompanied by disease burden and healthcare issues (Gilbert et al., 2019; Rasekaba et al., 2018). The high-risk factors associated with GDM include high maternal prepregnancy body weight, a family history of Type 2 diabetes, and previous pregnancy with glucose intolerance (Puhkala et al., 2013; Shen et al., 2019). Good control of blood glucose in GDM is important to minimize the risk of pregnancy-related complications such as premature birth, preeclampsia, and cesarean section births (Allehdan et al., 2019; Gilbert et al., 2019). Moreover, GDM has been associated with perinatal complications such as shoulder dystocia, fetal macrosomia, and neonatal death (Allehdan et al., 2019; Gilbert et al., 2019). Associations between GDM and increased risk of developing Type 2 diabetes (Rao et al., 2019; Werbrouck et al., 2019) and metabolic syndrome (MS) after delivery (Huvinen et al., 2018; Nouhjah et al., 2018) have been previously reported. Women with a history of GDM suffer from Type 2 diabetes in later life and face a seven-times-higher risk of MS and cardiovascular disease than women with no history of GDM (Hakkarainen et al., 2016; McKenzie-Sampson et al., 2018; Puhkala et al., 2017). MS is a clustering of cardiovascular disease risk factors, including dyslipidemia, hypertension, hyperglycemia, and abdominal obesity (Puhkala et al., 2017). A review study revealed that women with a history of GDM had a higher risk of developing MS than those without a history of GDM (relative risk [RR] = 2.36, 95% CI [1.77, 3.14]). Offsprings exposed to GDM in utero have a higher risk of developing MS than those not exposed to GDM in utero (RR = 2.07, 95% CI [1.26, 3.42]). Women diagnosed with GDM have an increased risk of developing MS during pregnancy (RR = 20.51, 95% CI [5.04, 83.55]; Pathirana et al., 2021). MS diagnoses are typically made at the first postpartum evaluation in accordance with the International Diabetes Federation classification (Alberti et al., 2005), with modifications made for Asian populations. A diagnosis is made if any three of the following five criteria are met: waist circumference (WC) of >= 80 cm, elevated blood pressure (BP; >= 130 or 85 mmHg), elevated TG (>= 150 mg/dl), reduced high-density lipoprotein (HDL) cholesterol (<50 mg/dl), and elevated fasting blood glucose (FBG; >= 100 mg/dl).

 

Women at high risk of GDM are encouraged to alter certain lifestyle habits and attend regular follow-up examinations. As pregnancy progresses, the burden on pregnant women and health services increase (Hakkarainen et al., 2016; McKenzie-Sampson et al., 2018; Puhkala et al., 2017). The general prevalence of GDM is rising, with medical and insurance systems facing difficulties in coping effectively with this burden (Carolan-Olah & Sayakhot, 2019). Although interventions such as yoga, physical activity classes, lifestyle adjustments, and face-to-face nutrition counseling are currently provided to women with GDM, these interventions are often limited by time and place restrictions that make it difficult for some women to access these health resources (H. Chen et al., 2018). Thus, there is a need for a sustainable, innovative, and effective care system for GDM women that includes self-care behavior education and strengthening (Carolan-Olah & Sayakhot, 2019; Mackillop et al., 2018).

 

In previous studies, web-based interventions have been shown to be effective in improving lifestyle modifications; implementing blood glucose self-monitoring; achieving blood-sugar-control, maternal, and neonatal outcomes that are equivalent to the outcomes experienced by pregnant women receiving standard hospital care; and effectively reducing the rate of cesarean section (Homko et al., 2012; Rasekaba et al., 2018; von Storch et al., 2019). Web-based interventions employ a tracking system to improve self-monitoring that uses dietary logs, physical logs, reminders, and graphic progress indicators and, through peer support or real-time feedback interactivity, allow women to interact with one another and their health providers (Carolan-Olah & Sayakhot, 2019). Using this type of intervention in diabetes prevention may empower women to obtain appropriate resources and make positive decisions about lifestyle change and chronic disease control (Given et al., 2015; Homko et al., 2012; Rasekaba et al., 2018).

 

Over the past two decades, Taiwan's total fertility rate has declined to one of the lowest in the world, with an average fertility rate of 1.3 children per woman (National Statistics, ROC, 2020). Consequently, developing health policies that prevent high-risk pregnancies, ensure a safe birth process, and protect the health of newborns and mothers should be prioritized. Systematic and meta-analysis appraisals of web-based interventions have been conducted for women at high risk of GDM (Rasekaba et al., 2018; Xie et al., 2020). However, only a few studies of MS and its postpartum components have been conducted in women who were found during early pregnancy to be at higher risk of developing GDM (Puhkala et al., 2013, 2017). Furthermore, long-term follow-up studies are lacking on the use of web-based interventions in preventing the development of MS in women at high risk of GDM.

 

The aim of this study was to examine the longitudinal effects on pregnant women at high risk of GDM of a nurse-led web-based health management program intervention that was initiated prior to 28 weeks of gestation and lasted through 6-12 weeks postpartum. Maternal anthropometric and metabolic profiles, including weight, body mass index (BMI), BP, FBG, TG levels, HDL levels, cholesterol levels, and WC, were used as the primary outcome measures. Pregnancy-related complications and neonatal outcomes were also accessed.

 

Methods

Study Design and Setting

This randomized controlled study without blinding was conducted between February 2017 and February 2018 during regular maternity clinic visits at a medical center in northern Taiwan that delivers approximately 4,000 births per year and has nine obstetricians on staff. The trial was registered at http://ClinicalTrails.gov. The randomization and concealed allocation procedures were independently handled by a statistician who did not participate in this study using random allocation software (Random Allocation Software 1.0.0) block arrangement random allocation (permuted block randomization), with the number of groups set to 2, the number of samples set to 112, and the area block equal sample set to 4. The random serial numbers and groups generated by the computer were placed in consecutively coded, sealed opaque envelopes.

 

Participants

The inclusion criteria included (a) singleton pregnancy, (b) less than 28 weeks of gestation, and (c) having at least one of the GDM risk factors listed by the National Institute for Health and Care Excellence (2015) modified for Asian populations (i.e., > 34 years old, prepregnancy BMI >= 24 kg/m2, a macrosomia baby [weight >= 4.5 kg], history of GDM in a previous pregnancy, and family history of diabetes). Pregnant women with preexisting diabetes (Type 1 or 2), with limited mobility or inability to perform physical exercise, or < 18 years old were excluded.

 

G*Power Version 3.1.1 (Heinrich Heine University, Dusseldorf, Germany) was used to estimate the minimum sample size (Faul et al., 2007). An F test with three repeated measurements for two independent groups was used. According to Cohen's (1988) rule for effect size, a sample of 70 is required to detect the differences in changes with an effect size of 0.25, a power of .80, and an alpha of .05 and, assuming a dropout rate of 20%-25%, a minimum sample size of 94 for the randomized controlled trial was needed in this study. A total of 112 participants were enrolled.

 

Measures

The participants in both groups filled out a questionnaire with demographic and health information at Time 0 (prior to 28 weeks of gestation). Anthropometric and metabolic measures were accessed at Time 0, Time 1 (36-40 weeks of gestation), and Time 2 (6-12 weeks postpartum). Maternal and neonatal outcome assessments were conducted at delivery.

 

Demographic characteristics

Demographic and personal health information with respect to height, prepregnancy bodyweight, parity, age, marital status, work status, educational level, family history of diabetes, previous history of premature birth or abortion, GDM, and preeclampsia was gathered using a self-report survey.

 

Maternal anthropometry and metabolic measures

To determine the effect of web-based health management on women's outcomes, the maternal anthropometric and metabolic profiles (weight, BMI, BP, FBG, cholesterol, HDL, and TG) for each participant were evaluated. The metabolic measures for analysis after a 12-hour fast were determined. The results were obtained in a hospital setting using laboratory instruments tested by the hospital quality control team. The data were collected from the medical records at the antenatal clinic by a researcher.

 

Women are typically screened for GDM at 24-28 weeks of gestation by clinical order if risk factors such as advanced maternal age, previous history of GDM, and previous history of fetal macrosomia were present. The International Association of Diabetes and Pregnancy Study Groups' 75-g oral glucose tolerance test was used to diagnose GDM. The participants drank 75 g of glucose in 330 ml of water, and the samples were taken after 60 and 120 minutes and assessed in accordance with the criteria for FBG, 1-hour, and 2-hour oral glucose tolerance test plasma glucose concentrations mean values (92, 180, and 153 mg/dl, respectively) proposed by the Hyperglycemia and Adverse Pregnancy Outcome Study (International Association of Diabetes and Pregnancy Study Groups Consensus Panel et al., 2010).

 

Maternal and neonatal outcomes

Maternal outcomes compared the diabetic control between the groups. Weight and BMI were recorded at each visit, as was pregnancy-induced hypertension or preeclampsia, gestational age at birth, birth weight, and the proportion of babies who were large for their gestational age (> 90th percentile for gestation and gender), mode of birth, and severe perineal trauma. Neonatal outcomes of interest included birth-related injuries and neonatal intensive care unit (NICU) admission. The data were collected from the medical records at the antenatal clinic by a researcher.

 

Nurse-Led Web-Based Health Management Intervention and Control

Development of a nurse-led web-based health management program

The development of the nurse-led web-based health management program was guided by discussion with an obstetrician, gynecologist, dietitian, sports coach (who provided pregnancy exercise guidance), nurse, and information technology engineer. The analysis, design, development, implementation, and evaluation model of system design (Reinbold, 2013) was applied to create the nurse-led web-based health management program (Figure 1). Twenty-two women with GDM were recruited using purposive sampling, and data were collected using in-depth, semistructured and open-ended interviews to explore the design needs of web-based health management. Themes were then mapped onto the web design (Table 1). The evaluation involved a two-stage process. In the first step, we invited nursing information experts and obstetrics and gynecology experts with clinical practice experience with GDM and MS (n = 5) to review the content relevance, wording clarity, and style design. The content validity index values were .97-.99. User evaluations were based on real case scenarios to simulate how women would use the system in a self-management process at home. We invited pregnant women with high risk of GDM of 30-40 years old (n = 10). They measured weight and BP, kept a diet and exercise log, recorded in paper logbooks, and input their personal health information into the website for 7 days. To confirm the consistency and stability of paper and electronic records, the intraclass correlation should be between .81 and .96. The researcher also interacted with the testers in 7 days to check network stability, operational convenience, and information content. The users evaluated the content relevance, wording clarity, and style design, finding the content validity index to be .91-.99. After evaluation, we made several modifications based on the experts' and users' suggestions. For example, the normal range of various metabolic indicators of the health plan were provided to help women set clear goals; embedded advertising was removed from videos and hyperlinks; and details for specific data upload, dietary, and exercise records were provided.

  
Figure 1 - Click to enlarge in new windowFigure 1. Diagram Depicting the Five Steps of Analysis, Design, Development, Implementation, and Evaluation Model.
 
Table 1 - Click to enlarge in new windowTable 1 Mapping of Themes Onto Website Constructs

Intervention group

The participants in the intervention group received the standard clinic-based education class and were invited to use the web-based health management program. Each participant had a unique account and website log-in password, which was encrypted using Secure Socket Layer. The website was enabled to count the number of log-ins by each participant and record user usage patterns. The system determined course participation, self-monitoring (records related to the diet diary and exercise log), and satisfaction with online health information. Each participant was required to log into the system at least once per week to fill in their weight measurements and complete the diet diary and exercise log. Reward points were given to participants every time they completed this task, and participants could redeem these points for gifts (e.g., maternity and baby products). This reward mechanism encouraged participants to record information frequently and develop self-monitoring and management competencies. The intervention also included one-on-one, 20- to 30-minute LINE consultation sessions after each blood sample report that facilitated the provision of tailored health education, reinforced strategies, and elicited participant feedback.

 

Control group

Women in this group attended standard clinic-based care sessions. Women diagnosed with GDM were provided with a face-to-face health education program related to diabetes (same as the intervention group, conducted by the same educator). This program comprised diet control and guidance related to exercise during pregnancy and maintaining a healthy lifestyle, with each session lasting approximately 1 hour. Because all of the participants were covered by Taiwan's national health insurance, participants followed the conventional schedule of examinations during pregnancy. Specifically, they received 10 examinations, with biweekly and weekly examinations conducted at 32-36 weeks and after 36 weeks, respectively.

 

Procedure

After institutional review board approval from the participating hospitals, three obstetrics and gynecological nurses with more than 5 years of respective experience assessed the eligibility of potential participants and obtained informed consent. These nurses were trained by the same researcher to ensure their understanding of the eligibility. To ensure the consistency and quality of the intervention, the intervention was carried out by one researcher. After the initial assessment, the qualified participants were transferred to the researcher to obtain consent. The researcher opened the envelopes in order and assigned the participants to the intervention group or control group according to the groups indicated on the envelope. The participants were randomly assigned to the intervention group or control group, and all of the participants received standard maternity care. With the intervention group, the researcher took approximately 15-30 minutes instructing each participant on using the website and setting up a personal account. The participants were then provided with the URL link or QR code and log-in password for the website and instructed that they could use the website at any time during the 6-month study period. To avoid interaction between the two groups, only the intervention group was permitted to log in with their account and password on the web-based health management program and to view/use the information.

 

The participants in the intervention group were required to log into the website at least once per week to complete dietary, exercise, and self-management information. Their health status levels, weight, and postpartum WC were also measured. The recruitment procedure is shown in Figure 2.

  
Figure 2 - Click to enlarge in new windowFigure 2. Consolidated Standards of Reporting Trials Flow Diagram.

Data Analysis

Data analysis was performed using SPSS/PC for Windows 20.0 (IBM, Inc., Armonk, NY, USA). A t test and a chi-square test were conducted to analyze the demographic variables of the participants and determine whether differences in essential attributes were detected between the groups. The data related to MS indicators were processed using an independent-sample t test and a chi-square test to determine whether differences existed between the intervention and control groups. The significance level was set at a two-tailed p value of .05. Generalized estimating equations were applied to analyze intervention effectiveness. An intervention effectiveness evaluation was conducted after the covariates were controlled to assess the levels of MS indicators prior to and after the intervention. The aforementioned data were processed using intention-to-treat analysis.

 

Ethical Considerations

This study was approved by the regional ethics board in Taiwan (Chang Gung Memorial Hospital IRB No. 105-4129C). The researcher explained the purpose of the study, and all potential participants provided written consent prior to enrollment. The participants were informed they could withdraw during the study at any time for any reason without explanation.

 

Results

Demographic Characteristics

The mean ages of participants in the intervention and control groups were 35.71 (SD = 4.31) and 35.82 (SD = 4.28) years, respectively. Forty-five and 38 participants in the two groups, respectively, completed the follow-up test. The descriptive analysis results are shown in Table 2. No significant difference between the groups in terms of sociodemographic and clinical characteristics was identified.

  
Table 2 - Click to enlarge in new windowTable 2 Baseline Characteristics and Components of Metabolic Syndrome, by Group (

Effect of Intervention on Risk Factors of Metabolic Syndrome

After the intervention, at Time 1, the levels of diastolic BP ([beta] = -4.98, p = .025) and TG ([beta] = -33.69, p = .020) were significantly lower in the intervention group than the control group. Similarly, at Time 2, the intervention group had more favorable TG ([beta] = -21.21, p = .036) and total cholesterol ([beta] = -41.25, p = .006) levels than the control group (Table 3). As shown in Table 4, the weight gain differences between the groups were nonsignificant. However, BMI during pregnancy increased by 4.07 kg/m2 (95% CI [3.7, 4.4]) in the intervention group and 4.75 kg/m2 (95% CI [4.2, 5.3]) in the control group (p = .025). At Time 2, the BMI increase was 1.24 kg/m2 (95% CI [0.9, 1.6]) in the intervention group and 1.93 kg/m2 (95% CI [1.3, 2.5]) in the control group (p = .045). The intervention group had seven fewer participants with a WC of >= 80 cm than the control group (p = .042).

  
Table 3 - Click to enlarge in new windowTable 3 Generalized Estimating Equation (GEE) of Baseline and Follow-Up Assessment of Changes in Metabolic Syndrome Markers in Two Groups (
 
Table 4 - Click to enlarge in new windowTable 4 Baseline Data and Changes From Baseline

Generalized estimating equations were used to analyze the BMI levels at prior to pregnancy, Time 0, Time 1, and Time 2. The results indicate that BMI increased with the number of pregnancy weeks in both groups. Subsequently, a significant interaction effect between groups and measurement times was observed. The results revealed that, on average, the average BMI level of the intervention group was 0.708 and 1.512 lower at Time 1 and Time 2, respectively, than that in the control group for the same time periods (p < .001). Thus, the web-based intervention was associated with a significant lowering in participant BMI levels. The follow-up results at Time 2 also showed that the number of individuals with MS decreased from 11 to 3 in the intervention group and from 14 to 10 in the control group, indicating that the intervention group achieved better performance in reversing MS ([chi]2 = 6.022, p = .014).

 

Effect of the Intervention on Maternal and Neonatal Outcomes

As shown in Table 5, no differences were found between groups in terms of birth method and NICU admission. The numbers of low birth weight and large-sized newborns in the intervention group were lower than those in the control group ([chi]2 = 6.729, p = .012). In terms of pregnancy complications, two participants in the intervention group were diagnosed with preeclampsia, whereas three participants in the control group separately developed preeclampsia, postpartum hemorrhage, and a fourth-degree perineal tear.

  
Table 5 - Click to enlarge in new windowTable 5 Maternal and Neonatal Outcomes in Participants (

Discussion

This study used an online self-management and learning system to improve conventional health management approaches, thereby helping participants improve MS risk factors. The prevalence of MS in the participants at Time 2 was 15.7%, which is slightly lower than the results obtained in other studies (Nouhjah et al., 2018; Puhkala et al., 2013). The dropout rate was 19.6% and 32.1% in the intervention and control groups, respectively. The stated reasons for withdrawal in the control group included the trouble involved in scheduling and making additional visits for blood tests at nonoutpatient times, switching doctors or hospitals for pregnancy examinations, tocolytic treatments, and preeclampsia-related hospitalization. The main stated reason for withdrawal in the intervention group was the burden of maintaining the dietary log. After delivery, participants did not fast for 12 hours before taking a blood test because of the need to breastfeed. Moreover, both groups were busy caring for their newborns and viewed themselves as healthy and not in need of follow-up examinations. Similar rates of failure and participant difficulties in similar studies of telemedicine in GDM have been reported (Bartholomew et al., 2015). The dropout rate in the control group exceeded expectations, and the overall statistical power of 80% in this group may have biased the findings.

 

Effectiveness of the Intervention in Reducing the Risk Factors of Metabolic Syndrome

The intervention group had significantly improved TG levels at Time 1, and the intervention group outperformed the control group in terms of both TG and total cholesterol level at Time 2. This finding is consistent with previous studies that offered lifestyle interventions to women with GDM (Grotenfelt et al., 2020). Although a significant difference was also noted in diastolic BP, the difference was in the normal range and was not deemed clinically significant. In addition, there were no significant differences in systolic BP, FBG, and HDL, because the average values of these indicators were normal at Time 0, Time 1, and Time 2. Prepregnancy obesity and excessive weight gain during pregnancy are essential predictors of MS development in women with GDM (Shen et al., 2019; Xu et al., 2014), indicating the importance of effective weight control in MS prevention efforts. By comparing BMI between gestation and postpartum periods, the findings of this study revealed a significantly smaller increase in BMI in the intervention group compared to the control group. Furthermore, fewer participants in the intervention group had abnormal WC, demonstrating that the intervention group controlled their weight more effectively. This finding indicates that an intervention using web-based health management may be widely accepted and highly feasible for young women to facilitate weight, blood lipid level, and WC management.

 

Eight of the 11 participants in the intervention group who had been diagnosed with MS at Time 0 had successfully reversed the syndrome at Time 2. By contrast, 10 participants in the control group still had MS. The change in MS risk between the two groups was significant, which corresponds with prior findings. Puhkala et al. (2013) offered a lifestyle intervention program to women with GDM. Their results indicated that MS incidence in the control group was 1.5 times higher than that in the intervention group at 1 year postpartum and that MS incidence among individuals with prepregnancy obesity was three times that of individuals with a normal weight at 1 year postpartum. Furthermore, the results of a prior literature review and meta-analysis support that lifestyle interventions may effectively prevent GDM and reduce the incidence/delay the development of GDM-related MS (Allehdan et al., 2019; Grotenfelt et al., 2020).

 

Notably, the level of effectiveness in decreasing MS (particularly in terms of the reversion of blood lipids) was significant in this study. The researchers reviewed the log-in conditions of diet diaries, finding that the participants consumed mainly high-calorie foods and staple foods and consumed few vegetables at the beginning of the intervention. Their daily diet recordings were similar. Because most of the participants had full-time jobs, they frequently ate high-calorie bento boxes for lunch. Some claimed that they deserved rich meals during pregnancy, particularly after overcoming morning sickness. Others used their unborn children as an excuse for eating whatever they wanted. However, the participants gradually ate a healthier diet after acquiring the correct knowledge related to nutrient consumption during pregnancy on the website, engaged in group discussions, and accepted suggestions from dietitians.

 

A previous literature review and meta-analysis supports that regular exercise prior to pregnancy and during early pregnancy has the potential to significantly reduce gestational weight gain (Wang et al. 2019). However, because of the many pregnancy-related taboos in Taiwan (e.g., being discouraged to carry heavy objects and being required to get more rest), 57.1% of Taiwanese women cease to engage in strenuous exercise after becoming pregnant (Tung et al., 2014). Using website guidance, this study encouraged women to engage in an active lifestyle during pregnancy. For example, the web-based health management system allowed the participants to participate in online exercises with customized exercise guidance. By maintaining a diet diary and exercise log on the website, sharing their exercise routines, and supporting others' posts in the discussion group, participants gradually reduced their MS risk.

 

Effects of the Intervention on the Participants and Their Newborns

No significant difference was observed between the two groups in terms of cesarean section, admission to NICUs, pregnancy complications, or premature birth, which corresponds to the results of similar studies (Given et al., 2015; Homko et al., 2012). The similar incidences of cesarean section in the two groups may be attributed to the Taiwanese belief that birth time affects one's fortunes in life (Shen Chen Ba Zi). Consequently, the main reason that Taiwanese mothers choose to undergo cesarean section is to deliver their child at a time deemed to be fortuitous. Whether having a cesarean section, usually conducted 2-4 weeks prior to the estimated date of birth, is associated with premature birth and pregnancy complications in overweight mothers requires further investigation. In addition, because Taiwan's national health insurance covers 10-14 pregnancy examinations, maternal-fetal problems are usually detected at an early stage. Furthermore, the two groups received similar examinations, leading to no difference in intervention effects on maternal-fetal health. Most newborns had a normal weight. However, the number of newborns with low birth weight in the intervention group was significantly lower than in the control group. This finding was different to those of other studies (Homko et al., 2012; Mackillop et al., 2018). It may be that the participants in this study had abnormal metabolic indicators, especially in terms of cholesterol and TGs. Previous studies have reported lower birth weight as associated with higher concentrations of total cholesterol (L. H. Chen et al., 2017; Nghiem-Rao et al., 2016). The intervention group had better cholesterol control, which may have contributed to this group having a more normal neonatal birth weight.

 

Limitations

The results of this study support the clinical value of web-based health management interventions delivered during pregnancy. However, this study is affected by several limitations. This study was conducted at a single medical center. Thus, the results may not be generalizable to other populations. Also, blinding was not possible because of the nature of the intervention. There was a high dropout rate at 6-12 weeks of postpartum, which may reflect a general trend among women of deemphasizing their own health to focus on taking care of their babies. Future studies should explore how to best balance being a mother and maintaining appropriate self-care. In this study, the normal BMI (18.2-23.9) and normal WC ratios were higher in the intervention group than the control group. Moreover, the TG (>= 150 mg/dl), total cholesterol, and MS levels were higher in the control group than the intervention group. Although no statistically significant difference was found between the two groups, the abovementioned differences may have had potential clinical significance. It is suggested that different sampling methods be used in future research to reduce potential biases.

 

Conclusions

The results of this study demonstrated that a nurse-led web-based health management program has the potential to effectively reduce BMI, WC, diastolic BP, cholesterol, and TG levels. This type of program may have a feasible clinical role to play in changing the current pregnancy care model. The findings may serve as a reference for health policy development in the future and provide meaningful suggestions for clinical practice.

 

The advantages of this study included the experimental design used, the random assignment of subjects, and the relatively long length of follow-up (early pregnancy through 6-12 weeks postpartum). Web-based health management represents an innovative use of current technologies for the prevention of MS in women with GDM, particularly in the Taiwan context. Pregnancy and childbirth are important health transition periods for women. Health providers should understand the factors affecting this transition and provide professional consultation and follow-up care using "anytime/anywhere" web-based programs to assist women with GDM at high risk. We suggest that web-based health management programs become a routine part of maternal and neonatal care because of the ability of this type of platform to provide information (e.g., health tracking, reminders and monitoring of metabolic risk factors after delivery) that is tailored to each user for the effective prevention of MS in women with GDM.

 

Acknowledgments

This study was supported by grants from the Ministry of Science and Technology in Taiwan (MOST 104-2511-S-255-004-MY2). We gratefully acknowledge all of the participants for their generous cooperation.

 

Author Contributions

Study conception and design: MCS, ASC, MYC, JCS

 

Data collection: MSC, ASC, MYC

 

Data analysis and interpretation: MCS, ASC, MYC, JCS

 

Drafting of the article: MCS, MYC, JCS

 

Critical revision of the article: MCS, ASC, JCS

 

References

 

Alberti K. G., Zimmet P., Shaw J.IDF Epidemiology Task Force Consensus Group. (2005). The metabolic syndrome-A new worldwide definition. The Lancet, 366(9491), 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8[Context Link]

 

Allehdan S. S., Basha A. S., Asali F. F., Tayyem R. F. (2019). Dietary and exercise interventions and glycemic control and maternal and newborn outcomes in women diagnosed with gestational diabetes: Systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Review, 13(4), 2775-2784. https://doi.org/10.1016/j.dsx.2019.07.040[Context Link]

 

Bartholomew M. L., Soules K., Church K., Shaha S., Burlingame J., Graham G., Sauvage L., Zalud I. (2015). Managing diabetes in pregnancy using cell phone/Internet technology. Clinical Diabetes, 33(4), 169-174. https://doi.org/10.2337/diaclin.33.4.169[Context Link]

 

Carolan-Olah M., Sayakhot P. (2019). A randomized controlled trial of a web-based education intervention for women with gestational diabetes mellitus. Midwifery, 68, 39-47. https://doi.org/10.1016/j.midw.2018.08.019[Context Link]

 

Chen H., Chai Y., Dong L., Niu W., Zhang P. (2018). Effectiveness and appropriateness of mHealth interventions for maternal and child health: Systematic review. JMIR Mhealth Uhealth, 6(1), Article e7. https://doi.org/10.2196/mhealth.8998[Context Link]

 

Chen L. H., Chen S. S., Liang L., Wang C. L., Fall C., Osmond C., Veena S. R., Bretani A. (2017). Relationship between birth weight and total cholesterol concentration in adulthood: A meta-analysis. Journal of Chinese Medical Association, 80(1), 44-49. https://doi.org/10.1016/j.jcma.2016.08.001[Context Link]

 

Cohen J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Erlbaum. [Context Link]

 

Faul F., Erdfelder E., Lang A. G., Buchner A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191. [Context Link]

 

Gilbert L., Gross J., Lanzi S., Quansah D. Y., Puder J., Horsch A. (2019). How diet, physical activity and psychosocial well-being interact in women with gestational diabetes mellitus: An integrative review. BMC Pregnancy and Childbirth, 19, Article No. 60. https://doi.org/10.1186/s12884-019-2185-y[Context Link]

 

Given J. E., Bunting B. P., O'Kane M. J., Dunne F., Coates V. E. (2015). Tele-Mum: A feasibility study for a randomized controlled trial exploring the potential for telemedicine in the diabetes care of those with gestational diabetes. Diabetes Technology & Therapeutics, 17(12), 880-888. https://doi.org/10.1089/dia.2015.0147[Context Link]

 

Grotenfelt N. E., Wasenius N., Eriksson J. G., Huvinen E., Stach-Lempinen B., Koivusalo S. B., Rono K. (2020). Effect of maternal lifestyle intervention on metabolic health and adiposity of offspring: Findings from the Finnish Gestational Diabetes Prevention Study (RADIEL). Diabetes & Metabolism, 46(1), 46-53. https://doi.org/10.1016/j.diabet.2019.05.007[Context Link]

 

Hakkarainen H., Huopio H., Cederberg H., Paakkonen M., Voutilainen R., Heinonen S. (2016). The risk of metabolic syndrome in women with previous GDM in a long-term follow-up. Gynecological Endocrinology, 32(11), 920-925. https://doi.org/10.1080/09513590.2016.1198764[Context Link]

 

Homko C. J., Deeb L. C., Rohrbacher K., Mulla W., Mastrogiannis D., Gaughan J., Santamore W. P., Bove A. A. (2012). Impact of a telemedicine system with automated reminders on outcomes in women with gestational diabetes mellitus. Diabetes Technology & Therapeutics, 14(7), 624-629. https://doi.org/10.1089/dia.2012.0010[Context Link]

 

Huvinen E., Eriksson J. G., Koivusalo S. B., Grotenfelt N., Tiitinen A., Stach-Lempinen B., Rono K. (2018). Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: Findings from the RADIEL study follow-up. Acta Diabetologica, 55(5), 493-501. https://doi.org/10.1007/s00592-018-1118-y[Context Link]

 

Metzger B. E., Gabbe S. G., Persson B., Buchanan T. A., Catalano P. A., Damm P., Dyer A. R., de Leiva A., Hod M., Kitzmiler J. L., Lowe L. P., McIntyre H. D., Oats J. J., Omori Y., Schmidt M. I.International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010). International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 33(3), 676-682. [Context Link]

 

Mackillop L., Hirst J. E., Bartlett K. J., Birks J. S., Clifton L., Farmer A. J., Gibson O., Kenworthy Y., Levy J. C., Loerup L., Rivero-Arias O., Ming W. K., Velardo C., Tarassenko L. (2018). Comparing the efficacy of a mobile phone-based blood glucose management system with standard clinic care in women with gestational diabetes: Randomized controlled trial. JMIR Mhealth Uhealth, 6(3), Article e71. https://doi.org/10.2196/mhealth.9512[Context Link]

 

McKenzie-Sampson S., Paradis G., Healy-Profitos J., St-Pierre F., Auger N. (2018). Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: A retrospective cohort study. Acta Diabetologica, 55, 315-322. https://doi.org/10.1007/s00592-017-1099-2[Context Link]

 

National Institute for Health and Care Excellence. (2015). Diabetes in pregnancy: Management from preconception to the postnatal period. https://www.nice.org.uk/guidance/ng3/chapter/1-Recommendations#gestational-diabe[Context Link]

 

National Statistics, ROC. (2020). Statistical yearbook of interior. Fertility rates of childbearing age women. https://www.moi.gov.tw/files/site_stuff/321/2/year/year.html (Original work published in Chinese) [Context Link]

 

Nghiem-Rao T. H., Dahlgren A. F., Kalluri D., Cao Y., Simpson P. M., Patel S. B. (2016). Influence of gestational age and birth weight in neonatal cholesterol response to total parenteral nutrition. Journal of Clinical Lipidology, 10(4), 891-897.e1. https://doi.org/10.1016/j.jacl.2016.03.005[Context Link]

 

Nouhjah S., Shahbazian H., Shahbazian N., Jahanfar S., Jahanshahi A., Cheraghian B., Mohammadi Z. D., Ghodrati N., Houshmandi S. (2018). Early postpartum metabolic syndrome in women with or without gestational diabetes: Results from life after gestational diabetes Ahvaz cohort study. Diabetes& Metabolic Syndrome: Clinical Research & Review, 12(3), 317-323. https://doi.org/10.1016/j.dsx.2017.12.027[Context Link]

 

Pathirana M. M., Lassi Z. S., Ali A., Arstall M. A., Roberts C. T., Andraweera P. H. (2021). Association between metabolic syndrome and gestational diabetes mellitus in women and their children: A systematic review and meta-analysis. Endocrine, 71, 310-320. https://doi.org/10.1007/s12020-020-02492-1[Context Link]

 

Puhkala J., Kinnunen T. I., Vasankari T., Kukkonen-Harjula K., Raitanen J., Luoto R. (2013). Prevalence of metabolic syndrome one year after delivery in Finnish women at increased risk for gestational diabetes mellitus during pregnancy. Journal of Pregnancy, 2013, Article 139049. https://doi.org/10.1155/2013/139049[Context Link]

 

Puhkala J., Raitanen J., Kolu P., Tuominen P., Husu P., Luoto R. (2017). Metabolic syndrome in Finnish women 7 years after a gestational diabetes prevention trial. BMJ Open, 7(3), Article e014565. https://doi.org/10.1136/bmjopen-2016-014565[Context Link]

 

Rao U., de Vries B., Ross G. P., Gordon A.Cochrane Pregnancy and Childbirth Group. (2019). Fetal biometry for guiding the medical management of women with gestational diabetes mellitus for improving maternal and perinatal health. Cochrane Database Systematic Review, 9, Article CD012544. https://doi.org/10.1002/14651858.CD012544.pub2[Context Link]

 

Rasekaba T. M., Furler J., Young D., Liew D., Gray K., Blackberry I., Lim W. K. (2018). Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM). Diabetes Research & Clinical Practice, 142, 276-285. https://doi.org/10.1016/j.diabres.2018.05.049[Context Link]

 

Reinbold S. (2013). Using the ADDIE model in designing library instruction. Medical Reference Services Quarterly, 32(3), 244-256. https://doi.org/10.1080/02763869.2013.806859[Context Link]

 

Shen Y., Li W., Leng J., Zhang S., Liu H., Li W., Wang L., Tian H., Chen J., Qi L., Yang X., Yu Z., Tuomilehto J., Hu G. (2019). High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes. Diabetes Research and Clinical Practice, 150, 219-226. https://doi.org/10.1016/j.diabres.2019.03.030[Context Link]

 

Tung C. T., Lee C. F., Lin S. S., Lin H.-M. (2014). The exercise patterns of pregnant women in Taiwan. The Journal of Nursing Research, 22(4), 242-249. https://doi.org/10.1097/jnr.0000000000000056[Context Link]

 

von Storch K., Graaf E., Wunderlich M., Rietz C., Polidori M. C., Woopen C. (2019). Telemedicine-assisted self-management program for Type 2 diabetes patients. Diabetes Technology & Therapeutics, 21(9), 514-521. https://doi.org/10.1089/dia.2019.0056[Context Link]

 

Wang J., Wen D., Liu X., Liu Y. (2019). Impact of exercise on maternal gestational weight gain: An updated meta-analysis of randomized controlled trials. Medicine (Baltimore), 98(27), Article e16199. https://doi.org/10.1097/MD.0000000000016199[Context Link]

 

Werbrouck A., Schmidt M., Putman K., Benhalima K., Verhaeghe N., Annemans L., Simoens S. (2019). A systematic review on costs and cost-effectiveness of screening and prevention of Type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory. Diabetes Research and Clinical Practice, 147, 138-148. https://doi.org/10.1016/j.diabres.2018.11.012[Context Link]

 

Xie W., Dai P., Qin Y., Wu M., Yang B., Yu Y. (2020). Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: An updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy and Childbirth, 20(1), Article No. 198. https://doi.org/10.1186/s12884-020-02892-1[Context Link]

 

Xu Y., Shen S., Sun L., Yang H., Jin B., Cao X. (2014). Metabolic syndrome risk after gestational diabetes: A systematic review and meta-analysis. PLOS ONE, 9(1), Article e87863. https://doi.org/10.1371/journal.pone.0087863[Context Link]